WebApr 11, 2024 · The company's 50 day moving average price is $26.96 and its two-hundred day moving average price is $26.25. Myovant Sciences (NYSE:MYOV - Get Rating) last posted its earnings results on Thursday, January 26th. The company reported ($0.59) earnings per share for the quarter, missing analysts' consensus estimates of ($0.56) by … WebMyovant Sciences is a biotech company that develops new treatments for infertility in women and prostate cancer in men. Acquired by Sumitovant Brisbane, California, United States 501-1000 Post-IPO Debt Public myovant.com 14,525 Highlights Stock Symbol NYSE:MYOV Total Funding Amount $340M Contacts 326 Employee Profiles 5 Investors 3
Sumitovant Biopharma and Sumitomo Pharma Announce Offer to …
WebMar 10, 2024 · Sumitovant is a technology-driven biopharmaceutical company accelerating development and commercialization of new potential therapies for patients with rare conditions and other diseases. WebMyovant is headquartered in London, the UK. Gain a 360-degree view of Myovant Sciences Ltd and make more informed decisions for your business Contact Us Headquarters United … greenleaf chopshop locations
Myovant Sciences: Jobs LinkedIn
WebApr 11, 2024 · Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of … WebOct 24, 2024 · MYOV announced late Sunday a deal to be acquired by Japanese pharmaceutical company Sumitomo Pharma Co., Ltd's DNPUF unit Sumitovant … WebOct 25, 2024 · Myovant Sciences focused on a single API and had a single shareholder own over half of its shares. While that led to an acquisition, it also limited the company's pre- and post-takeover valuation. greenleaf chopshop yelp